Melanoma News and Research

Latest Melanoma News and Research

Research suggests a potential new approach for halting the spread of pancreatic cancer

A new study carried out in mice, led by Queen Mary University of London, has identified cells that drive the spread of pancreatic cancer and discovered a weakness in these cells that could be targeted using existing drugs.

18 Oct 2023

Does inflammatory bowel disease have a causal relationship with extracolonic tumors?

Whether inflammatory bowel disease (IBD) is causally related to extracolonic cancers.

17 Oct 2023

Smart scalpels could pave the way for surgeries performed by robotic devices

Scalpels with built-in sensors could streamline training for surgeons and pave the way for procedures performed by robotic devices, a study suggests.

12 Oct 2023

New AI software achieves 100% detection rate for melanoma

Skin cancer detection using artificial intelligence (AI) software has rapidly improved, new research has shown, with the latest software reaching a 100% detection rate for melanoma.

11 Oct 2023

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year.

11 Oct 2023

New nanocapsule treatment boosts immune response against solid tumors

UCLA researchers have developed a new treatment method using a tiny nanocapsule to help boost the immune response, making it easier for the immune system to fight and kill solid tumors.

11 Oct 2023

Non-melanoma skin cancer causing greater number of global deaths than melanoma, study finds

Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the European Academy of Dermatology and Venerology (EADV) Congress 2023 has found.

10 Oct 2023

Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of Texas at Austin has found.

9 Oct 2023

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Challenges associated with the development and design of neoantigen cancer vaccines.

5 Oct 2023

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma.

4 Oct 2023

Is ChatGPT ready to be your next medical advisor?

Vanderbilt University researchers explored ChatGPT's potential in medical information provision to professionals and patients. While showing promise in delivering accurate, comprehensive medical insights, the need for continuous algorithm refinement and better source discernment were highlighted to fully harness ChatGPT's potential.

3 Oct 2023

Gene variants linked to higher risk for nodular melanoma identified

Researchers from The University of Queensland and The Alfred hospital in Melbourne have identified gene variants which may contribute to people being at higher risk for nodular melanoma.

3 Oct 2023

Metabolism-targeting drug could offer new hope for cancer-related fatigue

Cancer-related fatigue (CRF) is a debilitating yet all-too-common condition, which can severely affect quality of life for patients undergoing treatment.

3 Oct 2023

Mobile AI rivals specialists in diagnosing skin cancer, outperforms junior doctors

This multicenter clinical trial compared AI-powered mobile phone diagnostic tools with human medical experts in diagnosing pigmented skin cancer. The study found that the AI system was equivalent to specialists in accuracy and superior to novices, showcasing mobile technology's potential for accessible and accurate skin cancer diagnosis.

28 Sep 2023

Neoadjuvant immunotherapy shows promise in multiple cancer types

Treating cancer with immunotherapies known as an immune checkpoint blockade (ICB) prior to surgery (so-called neoadjuvant immunotherapy) has been a rapidly growing area of research, but the scientific community is just scratching the surface of what is possible, according to a review article co-authored by several current and former investigators from the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Kimmel Cancer Center.

28 Sep 2023

New approach could improve immune checkpoint inhibitor response in MTAP-deficient tumors

Loss of the "housekeeping" gene methylthioadenosine phosphorylase, or MTAP, is a common event in cancer.

28 Sep 2023

Discovery sheds new light on the chain of events in early embryonic development

A new discovery by researchers challenges our current understanding of gastrulation, the most important stage of early embryonic development.

27 Sep 2023

New form of cellular immunotherapy shows promise against brain tumors in mice

Scientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) successfully tested a new form of cellular immunotherapy against brain tumors in mice for the first time.

26 Sep 2023

Everyday chemicals linked to increased cancer risk, especially in women

This study identifies links between exposure to chemicals like PFAS, parabens, and phenols and increased cancer risk, particularly among women and across racial groups. The findings spotlight the role of environmental toxins in hormone-related cancers, suggesting new avenues for cancer prevention and mitigation strategies.

24 Sep 2023

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

A comprehensive review in Signal Transduction and Targeted Therapy delves into the versatility and effectiveness of mRNA vaccines, from their game-changing role in COVID-19 to potential applications in cancer and rare diseases. Despite drawbacks like stability and high immunogenicity, advancements in vaccine technology have poised mRNA platforms as a robust tool for both preventive and therapeutic interventions.

21 Sep 2023

Melanoma News and Research

Latest Melanoma News and Research

Research suggests a potential new approach for halting the spread of pancreatic cancer

Does inflammatory bowel disease have a causal relationship with extracolonic tumors?

Smart scalpels could pave the way for surgeries performed by robotic devices

New AI software achieves 100% detection rate for melanoma

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

New nanocapsule treatment boosts immune response against solid tumors

Non-melanoma skin cancer causing greater number of global deaths than melanoma, study finds

Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

Is ChatGPT ready to be your next medical advisor?

Gene variants linked to higher risk for nodular melanoma identified

Metabolism-targeting drug could offer new hope for cancer-related fatigue

Mobile AI rivals specialists in diagnosing skin cancer, outperforms junior doctors

Neoadjuvant immunotherapy shows promise in multiple cancer types

New approach could improve immune checkpoint inhibitor response in MTAP-deficient tumors

Discovery sheds new light on the chain of events in early embryonic development

New form of cellular immunotherapy shows promise against brain tumors in mice

Everyday chemicals linked to increased cancer risk, especially in women

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Melanoma News and Research

Latest Melanoma News and Research

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Newsletters you may be interested in